@article{11184,
  keywords = {Covid-19, adjuvent therapy, breast cancer, endocrine therapy < hormone therapy, pandemic, Prostate cancer},
  author = {N. Barclay and M. Català and A. Jödicke and D. Prieto-Alhambra and D. Newby and A. Delmestri and W . Y. Man and Serrano À and M. Moncusí},
  title = {Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study},
  year = {2024},
  journal = {Ther Adv Med Oncol},
  volume = {16},
  edition = {2024/06/04},
  pages = {17588359241253115},
  isbn = {1758-8340 (Print)1758-8340},
  doi = {10.1177/17588359241253115},
  note = {1758-8359
Barclay, Nicola L
Orcid: 0000-0002-6500-9909
Català, Marti
Jödicke, Annika M
Prieto-Alhambra, Daniel
Newby, Danielle
Delmestri, Antonella
Man, Wai Yi
Serrano, Àlvar Roselló
Moncusí, Marta Pineda
OPTIMA Consortium
Journal Article
England
Ther Adv Med Oncol. 2024 Jun 2;16:17588359241253115. doi: 10.1177/17588359241253115. eCollection 2024.},
  language = {eng},
}